Chicago-area hospitals aim to boost transplants with 'lung in a box'

May 28, 2018 by Lisa Schencker, Chicago Tribune

Emphysema crept up on Bob Falat, gradually robbing him of his ability to breathe.

The Lockport man, 72, had to use oxygen day and night after smoking for nearly 40 years—a habit he now calls the worst thing he's ever done. He was on the waiting list for a , but he wasn't sure he'd survive long enough to get it.

That's when his doctors at Loyola Medicine presented him with a new option: get a donor lung that initially might not have seemed healthy enough to use. Falat was hesitant, but there were few alternatives.

In January, Falat became the first person at Loyola to receive a lung using sometimes known as "lung in a box," as part of a clinical trial. The idea behind the technology is to see if donor lungs that once may have been discarded may be healthy enough to if given more time to evaluate.

It's an innovation that could offer promise to patients with serious lung conditions who might otherwise have a tough time getting transplants quickly, given that about 80 percent of donated lungs are now considered unusable. Some hospitals, such as University of Chicago Medical Center, have used the technology in-house, while others such as Loyola University Medical Center are flying lungs to a central location for testing.

Here's how it works: In what looks like a scene out of a science fiction movie, a donor lung is placed in a transparent dome and connected to a ventilator that blows air and oxygen into it, inflating and deflating it to mimic breathing. A solution of proteins and nutrients is pumped into the lung's blood vessels to keep it alive. Remaining donor blood and medications are diluted and filtered away. The lung is then observed and tested over the course of several hours to determine if it's healthy enough for transplant. The system can also improve the health of some lungs, such as by healing bruises and removing blood clots, making the organs ready for use.

Doctors hope the technology, called ex vivo lung perfusion and approved by the Food and Drug Administration for use in , can increase the supply of . Lungs can otherwise be more difficult to get than other organs used in transplants, often because they're damaged when potential donors are on life-support before they die. The lungs might, for example, become congested with fluid, or patients might contract pneumonia.

In Illinois, 42 people are waiting for lungs, including 10 who've been waiting for six months or longer, according to the U.S. Department of Health and Human Services. Nationally, 1,440 people are on waitlists for lungs, fewer than the numbers waiting for kidneys, livers or hearts. Last year in Illinois, 92 lung transplants were performed, including 39 at Loyola, the largest lung transplant center in the state.

"There are patients who unfortunately are dying while waiting for transplants," said Dr. Daniel Dilling, medical director of Loyola's lung transplant program. "This technology ... it's by definition increasing the pool of donor (lungs) available."

Loyola has had multiple lungs tested but only used one in a transplant.

The University of Chicago Medical Center has tested four lungs—two of which were transplanted, as part of a clinical trial separate from the one involving Loyola.

"This expands our donor pool to lungs that are almost perfect but not quite, to lungs we would have turned down before, and that translates to a shorter wait time for our patients," said Dr. Tae Song, surgical director of U. of C.'s lung transplant program.

But the technology can be costly, require staff with special training and may only be used infrequently, making it impractical for other hospitals to have their own systems. The clinical trial in which Loyola is taking part aims to find out if it's effective for hospitals to send lungs to facilities in central locations for testing. Loyola is flying its questionable lungs to a bioengineering company in Maryland for testing.

Not everyone, however, is rushing to adopt the technology. Northwestern Memorial Hospital, which started doing lung transplants about four years ago, doesn't see a need to use it at this point, said Dr. Ankit Bharat, the hospital's lung transplant director. No Northwestern patient has ever died waiting for a lung transplant and the hospital has relatively short wait times, he said.

"For us it didn't make sense to take a marginal lung we would not normally use," Bharat said. "No doubt it's a significant advancement in the field, but just because it's there doesn't mean that every patient needs it."

Dr. Christopher Wigfield, surgical director for transplantation at Advocate Christ Medical Center in Oak Lawn, also noted that though he considers the technology important, it can potentially create a significant cost because not all lungs tested will be usable.

But Dilling, with Loyola, hopes that the trial, if successful, will allow hospitals such as Loyola to continue using the technology to get more lungs to patients. The hospital is covering the additional costs of using the system as part of the clinical trial, he said. The hospital considers it an investment that could eventually pay off with more revenue from additional transplants performed and more lives saved.

Falat said that although he was initially wary of the technology, he now feels grateful he was able to benefit from it. Each day since the transplant has been a little better than the last. The grandfather of four isn't back to golfing yet, but he can go for walks again and go to the store.

"I look forward to the next day all the time because the best days, I hope, are still ahead of me," Falat said.

Explore further: Alcohol use before lung transplant increases time in hospital and on ventilator

Related Stories

Alcohol use before lung transplant increases time in hospital and on ventilator

May 16, 2018
Lung transplant patients who showed evidence of alcohol use before their transplants spent more time in the hospital and on the ventilator, according to a study by Loyola University Chicago and Loyola Medicine researchers.

Researchers investigate the potential of lung restoration for transplant

January 8, 2018
Q: What is the role of lung restoration in lung transplants? How does it work?

Older donor lungs should be considered for transplantation

November 9, 2017
With a scarcity of lungs available for transplantation, the use of lungs from donors older than age 60 has been shown to achieve reasonable outcomes and should be considered as a viable option, according to research published ...

Clues found to early lung transplant failure

May 21, 2018
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages ...

Loyola patient receives one of the world's quickest lung transplants

April 24, 2014
A Loyola University Medical Center patient has received one of the world's quickest lung transplants. Kenneth Baumgardner received the transplant just six days after going on the waiting list. And he went home after spending ...

Surgeons test technology with potential to expand lung transplant donor pool

April 7, 2016
Michele Coleman lay close to death last fall with end-stage lung disease when she got a second chance at life.

Recommended for you

Surprise finding—for very sick elderly, lighter sedation won't drop risk of postoperative delirium, study suggests

August 13, 2018
Johns Hopkins Medicine researchers say a study designed to see if reducing the amount of anesthesia reduces the risk of postoperative delirium in older patients surprisingly found that lighter sedation failed to do so in ...

Kidney transplant chains more effective in saving lives

August 9, 2018
New research from the UBC Sauder School of the Business has found that transplant societies which prioritize kidney transplant chains over kidney exchanges can increase the total number of transplants, thereby saving more ...

Surgical mesh implants may cause autoimmune disorders

July 31, 2018
Surgical mesh implants, often used for hernia or gynecological repair, may be the reason so many patients report symptoms of an autoimmune disorder, according to a University of Alberta rheumatologist.

Surgeons discuss options when the risks of surgery may be too high

July 27, 2018
In an essay published July 26 in the New England Journal of Medicine, Ira Leeds, M.D., research fellow, and David Efron, M.D., professor of surgery, both of the Johns Hopkins University School of Medicine, along with their ...

Blood plasma during emergency air transport saves lives

July 25, 2018
Two units of plasma given in a medical helicopter on the way to the hospital could increase the odds of survival by 10 percent for traumatically injured patients with severe bleeding, according to the results of a national ...

The dark side of antibiotic ciprofloxacin

July 25, 2018
The use of ciprofloxacin and other antibiotics of the class of fluoroquinolones may be associated with disruption of the normal functions of connective tissue, including tendon rupture, tendonitis and retinal detachment. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.